ClinVar Genomic variation as it relates to human health
NM_003060.4(SLC22A5):c.632A>G (p.Tyr211Cys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_003060.4(SLC22A5):c.632A>G (p.Tyr211Cys)
Variation ID: 6420 Accession: VCV000006420.24
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 5q31.1 5: 132384281 (GRCh38) [ NCBI UCSC ] 5: 131719973 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 23, 2014 Jun 17, 2024 Mar 26, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_003060.4:c.632A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_003051.1:p.Tyr211Cys missense NM_001308122.2:c.704A>G NP_001295051.1:p.Tyr235Cys missense NC_000005.10:g.132384281A>G NC_000005.9:g.131719973A>G NG_008982.2:g.19578A>G O76082:p.Tyr211Cys - Protein change
- Y211C, Y235C
- Other names
-
p.Y211C:TAT>TGT
- Canonical SPDI
- NC_000005.10:132384280:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
The Genome Aggregation Database (gnomAD), exomes 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00002
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
SLC22A5 | - | - |
GRCh38 GRCh37 |
1174 | 1217 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic/Likely pathogenic (7) |
criteria provided, multiple submitters, no conflicts
|
Mar 26, 2024 | RCV000006789.32 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Sep 19, 2023 | RCV000186136.15 | |
Pathogenic (1) |
no assertion criteria provided
|
Dec 2, 2020 | RCV002226443.9 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Feb 01, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000339309.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Zygosity: Single Heterozygote
Sex: mixed
|
|
Likely pathogenic
(Jul 15, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Renal carnitine transport defect
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV002055807.1
First in ClinVar: Jan 12, 2022 Last updated: Jan 12, 2022 |
|
|
Likely pathogenic
(Oct 21, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Renal carnitine transport defect
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002783394.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Sep 19, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000239161.11
First in ClinVar: Jul 18, 2015 Last updated: Sep 30, 2023 |
Comment:
Published functional studies found cells expressing the variant showed no carnitine transport activity compared to wild-type (Frigeni et al., 2017); In silico analysis supports that … (more)
Published functional studies found cells expressing the variant showed no carnitine transport activity compared to wild-type (Frigeni et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26828774, 25087612, 23379544, 10480371, 28841266, 32778825) (less)
|
|
Pathogenic
(Nov 17, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Renal carnitine transport defect
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001232818.5
First in ClinVar: Apr 15, 2020 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 211 of the SLC22A5 protein … (more)
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 211 of the SLC22A5 protein (p.Tyr211Cys). This variant is present in population databases (rs121908888, gnomAD 0.003%). This missense change has been observed in individual(s) with primary carnitine deficiency (PMID: 10480371). ClinVar contains an entry for this variant (Variation ID: 6420). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC22A5 function (PMID: 28841266). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 26, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Renal carnitine transport defect
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004201257.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(Jul 01, 1999)
|
no assertion criteria provided
Method: literature only
|
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000026985.3
First in ClinVar: Apr 04, 2013 Last updated: Sep 29, 2018 |
Comment on evidence:
In 2 unrelated patients with classic systemic carnitine deficiency (CDSP; 212140), Vaz et al. (1999) found homozygosity for the same missense mutation, 632A-G, which changes … (more)
In 2 unrelated patients with classic systemic carnitine deficiency (CDSP; 212140), Vaz et al. (1999) found homozygosity for the same missense mutation, 632A-G, which changes the tyrosine at amino acid position 211 into a cysteine (Y211C). The first patient had been reported by Rodrigues Pereira et al. (1988) and by Scholte et al. (1990). The second patient was admitted to hospital at 7 months of age because of failure to thrive. Physical examination showed dilated cardiomyopathy. Cardiac decompensation had existed from the age of 5 months. Treatment with digoxin and diuretics was started. At the age of 20 months, she presented with lowered consciousness, respiratory insufficiency, hypoglycemia, hyperammonemia, elevated transaminases, and low plasma carnitine concentrations. With carnitine therapy, improvement of the echocardiographic findings was noted by the age of 2 years. At the age of 5.5 years, the echocardiograph was almost normal. (less)
|
|
Pathogenic
(Dec 02, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Carnitine deficiency
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV002078309.1
First in ClinVar: Feb 13, 2022 Last updated: Feb 13, 2022 |
|
|
Pathogenic
(Dec 02, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Renal carnitine transport defect
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV002107432.1
First in ClinVar: Mar 28, 2022 Last updated: Mar 28, 2022 |
|
|
Likely pathogenic
(Dec 29, 2015)
|
no assertion criteria provided
Method: clinical testing
|
Renal carnitine transport defect
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000485512.2
First in ClinVar: Dec 06, 2016 Last updated: Dec 23, 2019 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Functional and molecular studies in primary carnitine deficiency. | Frigeni M | Human mutation | 2017 | PMID: 28841266 |
Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency. | Vaz FM | Human genetics | 1999 | PMID: 10480371 |
Primary carnitine deficiency. | Scholte HR | Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie | 1990 | PMID: 2199596 |
Cardiomyopathy associated with carnitine loss in kidneys and small intestine. | Rodrigues Pereira R | European journal of pediatrics | 1988 | PMID: 3215194 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SLC22A5 | - | - | - | - |
Text-mined citations for rs121908888 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.